Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cord Blood Stem Cells

Unrelated cord blood transplantation for thalassaemia: a single-institution experience of 35 patients

Abstract

Our study was designed to prospectively determine whether or not unrelated cord blood transplantation (CBT) can produce outcomes comparable to related donor transplantation for children with β-thalassaemia. In 35 patients, 40 transplants were performed between October 2003 and September 2009. HLA matching at enrolment was 6/6 (n=8), 5/6 (n=16), 4/6 (n=27), or 3/6 (n=1) by low-resolution HLA-A, -B, and high-resolution DRB1. These patients received non-manipulated grafts without ex vivo expansion or T-cell depletion. The median number of nucleated and CD34+ cells infused was 7.8 × 107/kg (range, 2.8–14.7 × 107/kg) and 4.0 × 105/kg (range, 1.7–19.9 × 105/kg), respectively. The 5-year OS and thalassaemia-free survival after the first transplant were 88.3 and 73.9%, respectively. The cumulative incidence of TRM at 2 years was 11.7%. Fourteen patients developed chronic skin GVHD. Thirty patients were alive and transfusion-independent with a Lansky performance score 80% achieved between 6 and 76 months post transplant (median, 36 months). These data compare acceptably with the survival rates of related-donor BMT for thalassaemia and suggest that patients without an available HLA-compatible sibling but who have well-matched unrelated donors should also be considered for CBT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Modell B, Darlison M . Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008; 86: 480–487.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Weatherall DJ, Clegg JB . Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 2001; 79: 704–712.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Angastiniotis M, Modell B, Englezos P, Boulyjenkov V . Prevention and control of haemoglobinopathies. Bull World Health Organ 1995; 73: 375–386.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Prasad VK, Kurtzberg J . Umbilical cord blood transplantation for non-malignant diseases. Bone Marrow Transplant 2009; 44: 643–651.

    Article  CAS  PubMed  Google Scholar 

  5. Neufeld EJ . Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood 2006; 107: 3436–3441.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Wagner JE, Barker JN, DeFor TE, Barker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.

    CAS  PubMed  Google Scholar 

  7. Benito AI, Diaz MA, Gonzalez-Vicent M, Sevilla J, Madero L . Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant 2004; 33: 675–690.

    Article  CAS  PubMed  Google Scholar 

  8. Morris CR, Singer ST, Walters MC . Clinical hemoglobinopathies: iron, lungs and new blood. Curr Opin Hematol 2006; 13: 407–418.

    CAS  PubMed  Google Scholar 

  9. Angelucci E, Baronciani D . Allogeneic stem cell transplantation for thalassemia major. Haematologica 2008; 93: 1780–1784.

    Article  PubMed  Google Scholar 

  10. Seghatchian J, Solheim BG . Current opinions on safer red cell transfusion practice and the appropriate use of alternative strategies. Transfus Apher Sci 2007; 37: 201–207.

    Article  PubMed  Google Scholar 

  11. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci 1995; 92: 10119–10122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Cappellini MD, Piga A . Current status in iron chelation in hemoglobinopathies. Curr Mol Med 2008; 8: 663–674.

    Article  CAS  PubMed  Google Scholar 

  13. Cazzola M, Borgna-Pignatti C, Locatelli F, Ponchio L, Beguin Y, De Stefano P . A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion 1997; 37: 135–140.

    Article  CAS  PubMed  Google Scholar 

  14. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101: 2137–2143.

    Article  CAS  PubMed  Google Scholar 

  15. Lucarelli G, Galimberti M, Giardini C, Polchi P, Angelucci E, Baronciani D et al. Bone marrow transplantation in thalassemia. The experience of Pesaro. Ann N Y Acad Sci 1998; 850: 270–275.

    Article  CAS  PubMed  Google Scholar 

  16. Hongeng S, Pakakasama S, Chuansumrit A, Sirachainan N, Kitpoka P, Udomsubpayakul U et al. Outcomes of transplantation with related- and unrelated-donor stem cells in children with severe thalassemia. Biol Blood Marrow Transplant 2006; 12: 683–687.

    Article  PubMed  Google Scholar 

  17. Resnick IB, Aker M, Tsirigotis P, Shapira MY, Abdul-Hai A, Bitan M et al. Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen. Bone Marrow Transplant 2007; 40: 957–964.

    Article  CAS  PubMed  Google Scholar 

  18. Locatelli F, De Stefano P . Innovative approaches to hematopoietic stem cell transplantation for patients with thalassemia. Haematologica 2005; 90: 1592–1594.

    CAS  PubMed  Google Scholar 

  19. Filipovich A, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–955.

    Article  PubMed  Google Scholar 

  20. Couriel D, Carpenter P, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J et al. Ancillary therapy and supportive care of chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary therapy and supportive care working group report. Biol Blood Marrow Transplant 2006; 12: 375–396.

    Article  PubMed  Google Scholar 

  21. O’Brien T, Eastlund T, Peters C, Neglia JP, Defor T, Ramsay NK et al. Autoimmune haemolytic anemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated transplants for non-malignant disease. Br J Haematol 2004; 127: 67–75.

    Article  PubMed  Google Scholar 

  22. Page KM, Mendizabal AM, Prasad VK, Martin PL, Parikh S, Wood S et al. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation. Biol Blood Marrow Transplant 2008; 14: 1108–1117.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Bachar-Lustig E, Rachamim N, Li HW, Lan F, Reisner Y . Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1995; 1: 1268–1273.

    Article  CAS  PubMed  Google Scholar 

  24. Brunstein CG, Wagner JE . Umbilical cord blood transplantation and banking. Annu Rev Med 2006; 57: 403–417.

    Article  CAS  PubMed  Google Scholar 

  25. Kurtzberg J . Update on umbilical cord blood transplantation. Curr Opin Pediatr 2009; 21: 22–29.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Brown JA, Boussiotis VA . Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol 2008; 127: 286–297.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Gaziev J, Sodani P, Polchi P, Andreani M, Lucarelli G . Bone marrow transplantation in adults with thalassemia: treatment and long-term follow-up. Ann N Y Acad Sci 2005; 1054: 196–205.

    Article  PubMed  Google Scholar 

  28. Locatelli F, Stefano PD . New insights into haematopoietic stem cell transplantation for patients with haemoglobinopathies. Br J Haematol 2004; 125: 3–11.

    Article  PubMed  Google Scholar 

  29. Cheuk DK, Mok AS, Lee AC, Chiang AK, Ha SY, Lau YL et al. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant 2008; 42: 319–327.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are indebted to the patients and their carers for participating in the externally audited results. The authors acknowledge and thank the Department of Health, Executive Yuan in Taiwan, for helping to conduct and supervise the clinical trial of cord blood transplantation. This work was supported by grant CMRPG4A0031 from the Chang Gung Medical Research Program.

The material contained in this paper has been presented at the following meetings:

1. Jaing TH, Wang B, Gjertson D, Law P, Petz L, Chow R. Unrelated Cord Blood Transplantation (UCBT) for Transfusion-Dependent Thalassemia a CIBMTR Audited Retrospective Analysis of 30 Consecutive Patients from a Single Center. Session Type: Oral Session, Board #131. 50th ASH annual meeting; San Francisco, CA, USA; 6–9 December 2008.

2. Jaing TH, Wang B, Gjertson D, Law P, Petz L, Chow R. Unrelated Cord Blood Transplantation (UCBT) for Transfusion-Dependent Thalassemia a CIBMTR Audited Retrospective Analysis of 30 Consecutive Patients from a Single Center. CIBMTR 2009 BMT Tandem Meeting; Tampa, Florida, USA; 11–15 February 2009.

3. Jaing TH. Transplantation of Patients with Transfusion-dependent Thalassemia. 8th Annual International Cord Blood Transplantation Symposium: San Francisco, CA, USA; 3–5 June 2010.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T-H Jaing.

Ethics declarations

Competing interests

The authors indicated no potential conflicts of interest. No honorarium or payment of expenses was given to authors to produce the paper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jaing, TH., Hung, IJ., Yang, CP. et al. Unrelated cord blood transplantation for thalassaemia: a single-institution experience of 35 patients. Bone Marrow Transplant 47, 33–39 (2012). https://doi.org/10.1038/bmt.2011.39

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.39

Keywords

This article is cited by

Search

Quick links